SCHEMBL20997699

SCHEMBL20997699

CCc1ccc(/C(=C/N)NN)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
PLK1 P53350 1/20 0.44
ALDH1A1 P00352 4/20 0.44
TDP1 Q9NUW8 1/20 0.39
CYP2C9 P11712 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
PLAU P00749 1/20 0.37
MAOA P21397 1/20 0.37
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
MAPT P10636 2/20 0.36
IDO1 P14902 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20997687 0.85 PLK1 (0.47) PLK1ALDH1A1TDP1LPLLIPG
SCHEMBL20997991 0.82 PLK1 (0.50) PLK1ALDH1A1CYP2C9HPGDKMT2A
SCHEMBL20997871 0.78 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1TDP1CYP2C9MAPT
SCHEMBL20997681 0.75 MASP2 (0.39) SMN1; SMN2ALDH1A1TDP1CYP2C9PLAU
SCHEMBL14852983 0.74 SMN1; SMN2 (0.57) SMN1; SMN2PLK1ALDH1A1TDP1CYP2C9
SCHEMBL1535943 0.74 PLK1 (0.70) SMN1; SMN2PLK1ALDH1A1TDP1TAS1R3
SCHEMBL20997690 0.74 LMNA (0.52) ALDH1A1TDP1MAOAMAPTKDM4E
SCHEMBL20998018 0.74 OGG1 (0.52) SMN1; SMN2ALDH1A1MAPTIDO1KDM4E
SCHEMBL20997849 0.74 MAOA (0.42) SMN1; SMN2MAOAIDO1KMT2ARAB9A
SCHEMBL20997910 0.73 CA1 (0.56) SMN1; SMN2PLK1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483147-A1 METALLOENZYME INHIBITOR COMPOUNDS Innocrin Pharmaceuticals, Inc. (US) 2019-05-15 EP disclosed